These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 38749344

  • 1. Androsin alleviates non-alcoholic fatty liver disease by activating autophagy and attenuating de novo lipogenesis.
    Singh A, Ansari A, Gupta J, Singh H, Jagavelu K, Sashidhara KV.
    Phytomedicine; 2024 Jul; 129():155702. PubMed ID: 38749344
    [Abstract] [Full Text] [Related]

  • 2. Picroside II attenuates fatty acid accumulation in HepG2 cells via modulation of fatty acid uptake and synthesis.
    Dhami-Shah H, Vaidya R, Udipi S, Raghavan S, Abhijit S, Mohan V, Balasubramanyam M, Vaidya A.
    Clin Mol Hepatol; 2018 Mar; 24(1):77-87. PubMed ID: 29254285
    [Abstract] [Full Text] [Related]

  • 3. Fanlian Huazhuo Formula alleviates high-fat diet-induced non-alcoholic fatty liver disease by modulating autophagy and lipid synthesis signaling pathway.
    Niu MY, Dong GT, Li Y, Luo Q, Cao L, Wang XM, Wang QW, Wang YT, Zhang Z, Zhong XW, Dai WB, Li LY.
    World J Gastroenterol; 2024 Aug 14; 30(30):3584-3608. PubMed ID: 39193572
    [Abstract] [Full Text] [Related]

  • 4. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor.
    Li T, Xu L, Zheng R, Wang X, Li L, Ji H, Hu Q.
    Phytomedicine; 2020 Mar 14; 68():153153. PubMed ID: 32018210
    [Abstract] [Full Text] [Related]

  • 5. Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis.
    Nasiri-Ansari N, Nikolopoulou C, Papoutsi K, Kyrou I, Mantzoros CS, Kyriakopoulos G, Chatzigeorgiou A, Kalotychou V, Randeva MS, Chatha K, Kontzoglou K, Kaltsas G, Papavassiliou AG, Randeva HS, Kassi E.
    Int J Mol Sci; 2021 Jan 15; 22(2):. PubMed ID: 33467546
    [Abstract] [Full Text] [Related]

  • 6. Protective effect of picroside I against hepatic fibrosis in mice via sphingolipid metabolism, bile acid biosynthesis, and PPAR signaling pathway.
    Xiong K, Shi M, Zhang T, Han H.
    Biomed Pharmacother; 2020 Nov 15; 131():110683. PubMed ID: 32942155
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
    Lee MR, Yang HJ, Park KI, Ma JY.
    Phytomedicine; 2019 Mar 01; 55():14-22. PubMed ID: 30668424
    [Abstract] [Full Text] [Related]

  • 9. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis.
    Yin X, Liu Z, Wang J.
    Phytomedicine; 2023 Oct 01; 119():155005. PubMed ID: 37562090
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
    Park EJ, Kim YM, Kim HJ, Jang SY, Oh MH, Lee DH, Chang KC.
    Eur J Pharmacol; 2016 Oct 05; 788():200-209. PubMed ID: 27343380
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hepatoprotective Principles from the Rhizomes of Picrorhiza kurroa.
    Sakamoto Y, Inoue N, Nakanishi Y, Ninomiya K, Yoshikawa M, Muraoka O, Manse Y, Morikawa T.
    Biol Pharm Bull; 2023 Oct 05; 46(6):848-855. PubMed ID: 37258151
    [Abstract] [Full Text] [Related]

  • 14. Hepatoprotective activity assessment of amino acids derivatives of picroside I and II.
    Dong P, Gao Z, Yin X, Li Z, Han H.
    Chem Biol Drug Des; 2021 Feb 05; 97(2):341-348. PubMed ID: 32931135
    [Abstract] [Full Text] [Related]

  • 15. Fumigaclavine C ameliorates liver steatosis by attenuating hepatic de novo lipogenesis via modulation of the RhoA/ROCK signaling pathway.
    Yu W, Gao Y, Zhao Z, Long X, Yi Y, Ai S.
    BMC Complement Med Ther; 2023 Aug 16; 23(1):288. PubMed ID: 37587459
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Complexity of gene paralogues resolved in biosynthetic pathway of hepatoprotective iridoid glycosides in a medicinal herb, Picrorhiza kurroa through differential NGS transcriptomes.
    Kharb A, Chauhan RS.
    Mol Genet Genomics; 2021 Jul 16; 296(4):863-876. PubMed ID: 33899140
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Gentiopicroside Ameliorates Oxidative Stress and Lipid Accumulation through Nuclear Factor Erythroid 2-Related Factor 2 Activation.
    Jin M, Feng H, Wang Y, Yan S, Shen B, Li Z, Qin H, Wang Q, Li J, Liu G.
    Oxid Med Cell Longev; 2020 Jul 16; 2020():2940746. PubMed ID: 32655764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.